Descriptor English: | Pentostatin | ||||||
Descriptor Spanish: |
Pentostatina
| ||||||
Descriptor Portuguese: | Pentostatina | ||||||
Descriptor French: | Pentostatine | ||||||
Entry term(s): |
2' Deoxycoformycin 2'-Deoxycoformycin CI 825 CI-825 CI825 Co-Vidarabine Deoxycoformycin Imidazo(4,5-d)(1,3)diazepin-8-ol, 3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (R)- NSC 218321 NSC-218321 NSC218321 Nipent |
||||||
Tree number(s): |
D03.383.742.680.350.200.700 D13.570.230.677 D13.570.685.350.200.700 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D015649 | ||||||
Scope note: | A potent inhibitor of ADENOSINE DEAMINASE. The drug induces APOPTOSIS of LYMPHOCYTES, and is used in the treatment of many lymphoproliferative malignancies, particularly HAIRY CELL LEUKEMIA. It is also synergistic with some other antineoplastic agents and has immunosuppressive activity. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Antineoplastic Agents Adenosine Deaminase Inhibitors |
||||||
Registry Number: | 395575MZO7 | ||||||
CAS Type 1 Name: | Imidazo(4,5-d)(1,3)diazepin-8-ol, 3-(2-deoxy-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (8R)- | ||||||
Previous Indexing: |
Azepines (1966-1978) Coformycin/analogs & derivatives (1979-1989) Deoxyribonucleosides (1971-1978) |
||||||
Public MeSH Note: | 1997 (1990); CO-VIDARABINE (now PENTOSTATIN) was indexed under VIDARABINE/*analogs & derivatives 1976-97 |
||||||
History Note: | 1997 (1990); for CO-VIDARABINE use PENTOSTATIN 1982-1997 |
||||||
DeCS ID: | 24830 | ||||||
Unique ID: | D015649 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1990/01/01 | ||||||
Date of Entry: | 1989/05/25 | ||||||
Revision Date: | 2018/06/13 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Pentostatin
- Preferred
Deoxycoformycin
- Related but not broader or narrower
NSC-218321
- Narrower
Co-Vidarabine
- Related but not broader or narrower
CI-825
- Narrower
Nipent
- Narrower
Concept UI |
M0023987 |
Scope note | A potent inhibitor of ADENOSINE DEAMINASE. The drug induces APOPTOSIS of LYMPHOCYTES, and is used in the treatment of many lymphoproliferative malignancies, particularly HAIRY CELL LEUKEMIA. It is also synergistic with some other antineoplastic agents and has immunosuppressive activity. |
Preferred term | Pentostatin |
Concept UI |
M000642654 |
Preferred term | Deoxycoformycin |
Entry term(s) |
2' Deoxycoformycin 2'-Deoxycoformycin Imidazo(4,5-d)(1,3)diazepin-8-ol, 3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (R)- |
Concept UI |
M0333703 |
Preferred term | NSC-218321 |
Entry term(s) |
NSC 218321 NSC218321 |
Concept UI |
M000638634 |
Preferred term | Co-Vidarabine |
Concept UI |
M0333704 |
Preferred term | CI-825 |
Entry term(s) |
CI 825 CI825 |
Concept UI |
M0474210 |
Preferred term | Nipent |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey